UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Sensitizing Protective Tumor Microenvironments to Antibody-Mediated Therapy

Cell, 2014-01, Vol.156 (3), p.590-602

2014

Volltextzugriff (PDF)

Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia

Nature communications, 2023-04, Vol.14 (1), p.2147-2147, Article 2147

2023

Volltextzugriff (PDF)

Tumor Metabolism as a Regulator of Tumor-Host Interactions in the B-Cell Lymphoma Microenvironment-Fueling Progression and Novel Brakes for Therapy

International journal of molecular sciences, 2019-08, Vol.20 (17), p.4158

2019

Volltextzugriff (PDF)

Author Correction: Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia

Nature communications, 2023-10, Vol.14 (1), p.6724-6724, Article 6724

2023

Volltextzugriff (PDF)

Cell cycle control in Richter transformation

Blood, 2021-09, Vol.138 (12), p.1005-1007

Pallasch, Christian P.

2021

Volltextzugriff (PDF)

Functional impact and molecular binding modes of drugs that target the PI3K isoform p110δ

Communications biology, 2023-06, Vol.6 (1), p.603-603, Article 603

2023

Volltextzugriff (PDF)

A DNA/HDAC dual‐targeting drug CY190602 with significantly enhanced anticancer potency

EMBO molecular medicine, 2015-04, Vol.7 (4), p.438-449

2015

Volltextzugriff (PDF)

Rewired NFκB signaling as a potentially actionable feature of activated B-cell-like diffuse large B-cell lymphoma

European journal of haematology, 2016-12, Vol.97 (6), p.499-510

2016

Volltextzugriff (PDF)

Myeloperoxidase is a critical mediator of anthracycline-induced cardiomyopathy

Basic research in cardiology, 2023-09, Vol.118 (1), p.36-36, Article 36

2023

Volltextzugriff (PDF)

Kinase activity profiling reveals contribution of G-protein signaling modulator 2 deficiency to impaired regulatory T cell migration in rheumatoid arthritis

Journal of autoimmunity, 2021-11, Vol.124, p.102726-102726, Article 102726

2021

Volltextzugriff (PDF)

miRs-138 and -424 control palmitoylation-dependent CD95-mediated cell death by targeting acyl protein thioesterases 1 and 2 in CLL

Blood, 2015-05, Vol.125 (19), p.2948-2957

2015

Volltextzugriff (PDF)

Mechanisms of Lymphoma Clearance Induced by High-Dose Alkylating Agents

Cancer discovery, 2019-07, Vol.9 (7), p.944-961

2019

Volltextzugriff (PDF)

Increased seroreactivity to glioma-expressed antigen 2 in brain tumor patients under radiation

PloS one, 2008-05, Vol.3 (5), p.e2164

2008

Volltextzugriff (PDF)

Incorporating Targeted Agents Into Future Therapy of Chronic Lymphocytic Leukemia

Seminars in hematology, 2014-07, Vol.51 (3), p.235-248

2014

Volltextzugriff (PDF)

Rapid generation of human B-cell lymphomas via combined expression of Myc and Bcl2 and their use as a preclinical model for biological therapies

Oncogene, 2013-02, Vol.32 (8), p.1066-1072

2013

Volltextzugriff (PDF)

B-cell receptor triggers drug sensitivity of primary CLL cells by controlling glucosylation of ceramides

Blood, 2012-11, Vol.120 (19), p.3978-3985

2012

Volltextzugriff (PDF)

The kinase inhibitor dasatinib induces apoptosis in chronic lymphocytic leukemia cells in vitro with preference for a subgroup of patients with unmutated IgVH genes

Blood, 2008-08, Vol.112 (4), p.1443-1452

2008

Volltextzugriff (PDF)

Macrophage-Mediated Antibody Dependent Effector Function in Aggressive B-Cell Lymphoma Treatment is Enhanced by Ibrutinib via Inhibition of JAK2

Cancers, 2020-08, Vol.12 (8), p.2303

2020

Volltextzugriff (PDF)

Detection of a novel truncating Merkel cell polyomavirus large T antigen deletion in chronic lymphocytic leukemia cells

Blood, 2010-12, Vol.116 (24), p.5280-5284

2010

Volltextzugriff (PDF)

Concepts of Chronic Lymphocytic Leukemia Pathogenesis: DNA Damage Response and Tumor Microenvironment

Oncology research and treatment, 2016-01, Vol.39 (1-2), p.9-16

2016

Volltextzugriff (PDF)

Disruption of T cell suppression in chronic lymphocytic leukemia by CD200 blockade

Leukemia research, 2009-03, Vol.33 (3), p.460-464

2009

Volltextzugriff (PDF)

Novel X‐linked inhibitor of apoptosis inhibiting compound as sensitizer for TRAIL‐mediated apoptosis in chronic lymphocytic leukaemia with poor prognosis

British journal of haematology, 2011-01, Vol.152 (2), p.191-200

2011

Volltextzugriff (PDF)

1 – 25 von 63

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(61)

Publikationsform

Sprache

Englisch
(62)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Sensitizing Protective Tumor Microenvironments to Antibody-Mediated Therapy

Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia

Tumor Metabolism as a Regulator of Tumor-Host Interactions in the B-Cell Lymphoma Microenvironment-Fueling Progression and Novel Brakes for Therapy

Author Correction: Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia

Cell cycle control in Richter transformation

Functional impact and molecular binding modes of drugs that target the PI3K isoform p110δ

A DNA/HDAC dual‐targeting drug CY190602 with significantly enhanced anticancer potency

Extracellular vesicles and PD-L1 suppress macrophages inducing therapy resistance in TP53-deficient B-cell malignancies

Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1

Rewired NFκB signaling as a potentially actionable feature of activated B-cell-like diffuse large B-cell lymphoma

Myeloperoxidase is a critical mediator of anthracycline-induced cardiomyopathy

Kinase activity profiling reveals contribution of G-protein signaling modulator 2 deficiency to impaired regulatory T cell migration in rheumatoid arthritis

miRs-138 and -424 control palmitoylation-dependent CD95-mediated cell death by targeting acyl protein thioesterases 1 and 2 in CLL

Lenalidomide enhances MOR202-dependent macrophage-mediated effector functions via the vitamin D pathway

Mechanisms of Lymphoma Clearance Induced by High-Dose Alkylating Agents

Increased seroreactivity to glioma-expressed antigen 2 in brain tumor patients under radiation

Incorporating Targeted Agents Into Future Therapy of Chronic Lymphocytic Leukemia

Rapid generation of human B-cell lymphomas via combined expression of Myc and Bcl2 and their use as a preclinical model for biological therapies

B-cell receptor triggers drug sensitivity of primary CLL cells by controlling glucosylation of ceramides

The kinase inhibitor dasatinib induces apoptosis in chronic lymphocytic leukemia cells in vitro with preference for a subgroup of patients with unmutated IgVH genes

Macrophage-Mediated Antibody Dependent Effector Function in Aggressive B-Cell Lymphoma Treatment is Enhanced by Ibrutinib via Inhibition of JAK2

Detection of a novel truncating Merkel cell polyomavirus large T antigen deletion in chronic lymphocytic leukemia cells

Concepts of Chronic Lymphocytic Leukemia Pathogenesis: DNA Damage Response and Tumor Microenvironment

Disruption of T cell suppression in chronic lymphocytic leukemia by CD200 blockade

Novel X‐linked inhibitor of apoptosis inhibiting compound as sensitizer for TRAIL‐mediated apoptosis in chronic lymphocytic leukaemia with poor prognosis

Suchergebnisse filtern